Cutaneous T-Cell Lymphoma (CTCL) Completed Phase 2 Trials for Forodesine (DB06185)

Also known as: Lymphoma, Cutaneous T-Cell / Cutaneous T-Cell Lymphomas / Cutaneous T-Cell Lymphoma / Cutaneous lymphoma / Lymphoma, T-Cell, Cutaneous

IndicationStatusPhase
DBCOND0071861 (Cutaneous T-Cell Lymphoma (CTCL))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00501735Forodesine in the Treatment of Cutaneous T-Cell LymphomaTreatment